PSOAS MUSCLE ATTENUATION MEASUREMENT WITH COMPUTED TOMOGRAPHY INDICATES INTRA-MUSCULAR FAT ACCUMULATION IN PATIENTS WITH THE HIV-
|
|
- Chad Powers
- 5 years ago
- Views:
Transcription
1 Articles in PresS. J Appl Physiol (May 23, 2003) /japplphysiol PSOAS MUSCLE ATTENUATION MEASUREMENT WITH COMPUTED TOMOGRAPHY INDICATES INTRA-MUSCULAR FAT ACCUMULATION IN PATIENTS WITH THE HIV- LIPODYSTROPHY SYNDROME Martin Torriani 1, Colleen Hadigan 2, Megan E. Jensen 1, Steven Grinspoon 2 1 Division of Musculoskeletal Radiology and 2 Program In Nutritional Metabolism, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts Funded in part by NIH Grants DK59535, RR300088, and RR Contact information Martin Torriani, M.D. Division of Musculoskeletal Radiology Department of Radiology, Massachusetts General Hospital 15 Parkman Street WACC 515 Boston, MA Phone: Fax: mtorriani@hms.harvard.edu Running head PSOAS MUSCLE ATTENUATION VALUES IN HIV-LIPODYSTROPHY Copyright (c) 2003 by the American Physiological Society.
2 JAP ABSTRACT The HIV-lipodystrophy syndrome is characterized by abnormalities of lipid metabolism, glucose homeostasis and fat distribution. Overaccumulation of intra-muscular lipid may contribute to insulin resistance in this population. We examined 63 men: HIV-positive with lipodystrophy (n=22), HIV-positive without lipodystrophy (n=20), and age- and body mass indexmatched HIV-negative controls (n=21). Single slice computed tomography (CT) was used to determine psoas muscle attenuation and visceral fat area. Plasma free fatty acids (FFA), lipid profile, and markers of glucose homeostasis were measured. Muscle attenuation was significantly decreased in subjects with lipodystrophy [median (inter-quartile range), 55.0 ( )] compared to subjects without lipodystrophy [57.0 ( ); P=0.05] and HIV-negative controls [59.5 ( ); P<0.01]. Among HIV-infected subjects, muscle attenuation correlated significantly with FFA (r=-0.38; P=0.02), visceral fat (r=-0.49; P=0.002), glucose (r=-0.38; P=0.02) and insulin (r=-0.60; P=0.0001) response to 75-g OGTT. In forward stepwise regression analysis with psoas attenuation as the dependent variable, visceral fat (P=0.02) and FFA (P <0.05), but neither BMI, subcutaneous fat nor antiretroviral use, were strong independent predictors of muscle attenuation (r 2 =0.39 for model). Muscle attenuation (P=0.02) and visceral fat (P=0.02), but not BMI, subcutaneous fat, FFA, or antiretroviral use, were strong independent predictors of insulin response (area under the curve) to glucose challenge (r 2 =0.47 for model). These data demonstrate that decreased psoas muscle attenuation due to intra-muscular fat accumulation may contribute significantly to hyperinsulinemia and insulin resistance in HIVlipodystrophy patients. Further studies are needed to assess the mechanisms and consequences of intra-muscular lipid accumulation in HIV-infected patients. KEYWORDS Muscle attenuation; insulin resistance; protease inhibitor; acquired immunodeficiency syndrome
3 JAP INTRODUCTION HIV-infected patients receiving highly active antiretroviral therapy often demonstrate fat redistribution, characterized by subcutaneous fat loss and visceral fat hypertrophy. Changes in fat distribution are often seen in association with insulin resistance and dyslipidemia and overall lipolysis rates are increased among such patients (17). Excess free fatty acids from lipolysis may accumulate in muscle and thereby affect glucose entry and subsequent phosphorylation. Recent studies in this population using proton magnetic resonance (MR) spectroscopy demonstrate increased intramyocellular lipid concentrations (13; 22). Muscle attenuation values obtained with computerized tomography (CT) decrease as a function of augmented lipid concentrations, and are important independent markers of insulin resistance in non-hiv-infected patients with obesity and type 2 diabetes (15; 16). However, prior studies using CT scan have not compared muscle attenuation as a surrogate index of intramyocellular fat content in relationship to body composition and metabolic variables in HIV-infected individuals. MATERIALS AND METHODS Experimental Subjects and Protocol Attenuation values of psoas muscles were obtained by computed tomography (CT) in 22 HIV-infected men with lipodystrophy syndrome (LIPO), 20 HIV-infected men without lipodystrophy (NONLIPO), and 21 HIV-negative male control subjects (CTRL) recruited from the multidisciplinary HIV practice at the Massachusetts General Hospital. Subjects were referred for evaluation of observed changes in fat distribution, and also recruited from advertisements seeking HIV-infected patients with and without evidence of fat redistribution. HIV status was confirmed by enzyme-linked immunosorbent assay and Western blot testing in all subjects. Lipodystrophic subjects were selected based on a waist-to-hip ratio more than 0.95 and a history of significant change in fat distribution in the trunk, extremities, neck, or face. In all LIPO cases, the presence of changes in fat distribution was confirmed by physical
4 JAP examination and scored by a single investigator as severe (1.5 on a scale of 0 2) in 1 or more areas. Severe LIPO was scored for changes obvious to the casual observer and mild-tomoderate LIPO for changes noticeable to the patient and confirmed by the single investigator. Objective criteria used in the determination of severe LIPO included, but were not limited to, prominent peripheral venomegaly and a palpable dorsocervical fat pad. In contrast, HIVpositive, NONLIPO subjects were recruited from advertisements seeking HIV-infected men without changes in fat distribution. NONLIPO subjects were selected based on a waist-to-hip ratio less than 0.95 and did not demonstrate significant fat redistribution in any area on physical examination. Lipodystrophy patients were classified as having significant peripheral lipoatrophy if they demonstrated moderate or severe fat loss in the arms or legs. HIV-infected subjects receiving antiretroviral medications were on a stable regimen for more than 6 weeks. One subject in the LIPO group was receiving stable thyroid hormone replacement. No other subjects were known to have thyroid disease. To prevent enrollment of subjects with primary HIV-related wasting, patients with a BMI less than 20 kg/m 2 were excluded from all groups. Subjects receiving testosterone, growth hormone, anabolic hormones, glucocorticoid, antidiabetic agents, and megestrol acetate were excluded. Exclusion criteria also included known diabetes mellitus, hemoglobin level less than 9.0 g/dl, and age more than 60 and less than 18 years. The non-hiv-infected control subjects were in good health, using no medications, with a waist-to-hip ratio less than Written informed consent was obtained from each subject before testing, in accordance with the Committee on the use of Humans as Experimental Subjects of the Massachusetts Institute of Technology and the Subcommittee on Human Studies at the Massachusetts General Hospital. Body composition by CT scan and dual energy X-ray absorptiometry (DEXA), and metabolic indices such as fasting lipid levels, insulin, glucose, oral glucose tolerance test (OGTT), plasma FFA, CD4 count, and HIV viral load were also assessed. Body composition and other endocrine data have previously been reported in this subpopulation (25; 31).
5 JAP Experimental methods CT attenuation of psoas muscle. All scans were performed with a LightSpeed CT scanner (General Electric, Milwaukee, WI). A lateral scout image of the abdomen was obtained to identify the L4 pedicle, which served as a landmark for a single-slice image at this level. Scan parameters for each image were standardized (144 cm table height, 80 kv, 70 ma, 2 seconds, 1 cm slice thickness, 48 cm field of view). Bilateral psoas muscle attenuation values were measured utilizing Impax workstations (AGFA Diagnostic Software, version 4; Agfa, Ridgefield Park, NJ). A circular region of interest (ROI) with area of 1.5 cm 2 was placed in the most homogenous area of the muscle, avoiding visible intra-muscular fat (Figure 1). A single measurement was obtained from each side, and average psoas muscle attenuation value was calculated and expressed in Hounsfield units (HU). Body composition analysis. The single cross-sectional CT image at L4 was utilized to assess distribution of subcutaneous and visceral abdominal fat. Fat attenuation values were set at -50 to -250 HU as described by Borkan et al. (5) and intra-abdominal visceral and subcutaneous fat areas were determined based on tracings obtained utilizing commercial software (Alice, Parexel Inc., Waltham, MA). Abdominal visceral (VAT) and subcutaneous fat (SAT) and the ratio of VAT: total abdominal cross-sectional area were determined. Fat and fat-free mass were determined by dual-energy x-ray absorptiometry (DEXA) using a Hologic 4500 densitometer (Hologic, Inc., Waltham, MA). The technique has a precision error of 3% for fat and 1.5% for fat-free mass (23). Baseline weight was determined after an overnight fast and percent IBW was calculated based on standard height and weight tables (26). Waist-to-hip ratio was determined from the circumferential measurements of the waist at the level of the umbilicus and the hips at the level of the iliac crest taken with the patient in an upright standing position.
6 JAP Hormonal assessment and laboratory methods. Serologic assessment included fasting plasma FFA, triglycerides, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and total cholesterol. A standard 75-g oral glucose tolerance test with insulin and glucose levels, CD4, and HIV viral load were also performed. All parameters were determined using previously published methods (20; 31). Statistical analysis. Comparisons were made between the groups (LIPO vs. NONLIPO, LIPO vs. CTRL, and NONLIPO vs. CTRL) by the Wilcoxon rank sum test. Chi-square analysis was used to assess group differences for categorical variables. Univariate regression analyses were performed, comparing CT attenuation values and indices of body fat and composition among all HIV-infected patients. Forward stepwise regression analysis, P = 0.1 to enter the model, was performed to determine relevant factors contributing to muscle attenuation and hyperinsulinemia. Statistical significance was defined as P < Results are median plus interquartile range. Statistical analyses were made using JMP Statistical Database Software (SAS Institute, Inc., Cary, NC). RESULTS Age and BMI were not significantly different between the groups (Table 1). As previously reported, no significant difference in whole-body fat mass measured by DEXA was detected between groups (31). Regional trunk fat was increased, and extremity fat decreased in LIPO compared to NONLIPO and CTRL subjects. The NONLIPO and CTRL groups showed no significant difference in either truncal or extremity fat. LIPO subjects demonstrated significantly increased visceral fat area and visceral fat to total abdominal cross-sectional area determined by CT, compared with NONLIPO and CTRL subjects. No significant differences in visceral fat area were observed between NONLIPO and CTRL subjects. CD4 cell count and HIV viral load were not significantly different between HIV-infected groups, although duration of HIV, protease
7 JAP inhibitor (PI) use and nucleoside reverse transcriptase inhibitor (NRTI) use were greater in lipodystrophic patients when compared to the NONLIPO group (Table 1). The mean psoas muscle attenuation value measured by CT was significantly lower in the LIPO subjects, compared with NONLIPO and CTRL subjects (Figure 2). A significant difference was also seen between attenuation values of NONLIPO and CTRL (P < 0.05). Among HIV-infected subjects, BMI, waist-to-hip ratio, and body composition measurements were highly inversely related to psoas muscle attenuation (Table 2). Trunk fat measured by DEXA (r = -0.50, P = 0.002), visceral fat by CT (r = -0.49, P = 0.002) and whole-body fat by DEXA (r = -0.32, P = 0.05) correlated inversely with psoas muscle attenuation. In contrast, subcutaneous fat by CT was not significantly associated with psoas attenuation values. Additionally, plasma FFA, LDL, total cholesterol, and glucose and insulin area under the curve during OGTT were significantly inversely related to muscle attenuation determined by CT scan (Table 2). A forward stepwise regression analysis was performed with psoas muscle attenuation value as the dependent variable (Table 3). Visceral fat, BMI, plasma FFA, and subcutaneous fat area, PI and NRTI use were tested as independent variables utilizing a probability to enter of 0.1. The resulting whole model r 2 value was 0.39, and demonstrated that visceral fat (P = 0.02) and plasma FFA (P <0.05), but not BMI, subcutaneous fat or antiretroviral use, were strong predictors of psoas muscle attenuation. To determine the effect of muscle attenuation on hyperinsulinemia we also performed forward stepwise regression analysis for insulin AUC (Table 3). Psoas attenuation, visceral fat, BMI, subcutaneous fat area, FFA, PI and NRTI use were tested as independent variables utilizing a probability to enter of 0.1. Both muscle attenuation (P = 0.02) and visceral fat (P = 0.02), but not BMI, subcutaneous fat, FFA or antiretroviral use were strong independent predictors of insulin area under the curve (r 2 = 0.47 for model). This model indicated that a decrease of 1 HU in psoas attenuation (2% of median, 56 HU) predicted an increase in insulin AUC of 776 µiu/ml (14% of median, 5491 µiu/ml).
8 JAP DISCUSSION The HIV-lipodystrophy syndrome is characterized by increased visceral adiposity, loss of subcutaneous extremity fat, insulin resistance and dyslipidemia (9; 10; 27; 36). The mechanisms of the syndrome are unknown and may be related to protease inhibitor or nuclease reverse transcriptase inhibitor effects (8; 21) or an interaction of drug and non-drug factors. In addition, it is not known whether the HIV-lipodystrophy syndrome represents a single pathophysiological entity or several distinct subsyndromes. Hypertriglyceridemia is associated with increased concentrations of muscle lipid and insulin resistance in animal models (11), healthy subjects (3), obese and type 2 diabetics (15; 29). Intra-muscular lipid may contribute to skeletal muscle insulin resistance through inhibition of insulin signaling at PI-3 kinase and related inhibition of glucose transport (30). The extent and metabolic consequences of intramuscular lipid accumulation in HIV-infected patients with fat redistribution remains unknown. In non-hiv-infected patients, data obtained with CT suggest skeletal muscle attenuation decreases as a function of augmented lipid concentrations (14), and is an important independent marker of insulin resistance in obesity and type 2 diabetes (15; 16). Goodpaster et al. (14) have validated CT attenuation values of psoas, thigh and calf muscles as reliable indicators of lipid content. CT attenuation values of skeletal muscle have not previously been assessed in HIV lipodystrophy, and the relationship between muscle attenuation value, body composition, plasma FFA and glucose homeostasis remains unknown in this syndrome. Our study demonstrates low CT attenuation values of the psoas muscle in HIV lipodystrophic patients. Furthermore, CT attenuation values correlate significantly with insulin response to OGTT and plasma FFA. The LIPO subjects in our study had a mixed lipodystrophy pattern with predominant visceral hypertrophy. Visceral fat was increased to nearly twice the level of controls, whereas subcutaneous fat area was decreased by only 23% in comparison to BMImatched control subjects. Visceral fat area was a significant predictor of muscle attenuation values in HIV-infected individuals, whereas subcutaneous fat area was not significantly
9 JAP associated with psoas muscle attenuation in either univariate or multivariate regression analysis. Increased basal rates of lipolysis and plasma FFA have been demonstrated in patients with HIV infection and fat redistribution receiving highly active antiretroviral therapy (17; 24; 32; 33; 36). Increased lipolysis was recently shown to be a strong predictor of insulin resistance in HIV-infected men (17), and improved insulin sensitivity was demonstrated after acute inhibition of lipolysis with acipimox in this population (18). Results from the current study extend these prior observations and demonstrate increased intra-muscular lipid in HIV-infected patients, in association with fat distribution and FFA. Furthermore, our data is in agreement with the results of Behrens et al. (1) demonstrating hyperinsulinemia and reduced insulin-mediated glucose uptake of skeletal muscle in HIV-lipodystrophic patients with increased levels of FFA. Visceral fat area, but not subcutaneous fat area, was highly related to CT attenuation. In stepwise regression modeling, visceral fat remained strongly associated with muscle attenuation, in a model including PI and NRTI use as well as BMI. These data are consistent with and extend those of Gan et al. (13), demonstrating a relationship between visceral, but not subcutaneous, fat and intramyocellular lipid by proton MR spectroscopy in this population. Our results support the hypothesis that the lipodystrophy syndrome represents several distinct subsyndromes in which lipoatrophy per se is not associated with intra-muscular lipid accumulation and is related to use and duration of NRTI therapy (2; 12). In contrast, our data suggest that visceral adiposity and a marked metabolic syndrome is associated with intramuscular lipid accumulation. Although the mechanism of visceral hypertrophy is not known, preliminary data suggest that use of protease inhibitors may contribute to visceral fat accumulation, and related insulin resistance and dyslipidemia (10). Of note, the NONLIPO group also demonstrated decreased psoas muscle attenuation, although not to the same degree as the LIPO patients. This suggests a spectrum of metabolic derangement among HIVinfected patients that is not entirely defined by the presence of fat redistribution.
10 JAP We demonstrate that muscle attenuation is a strong predictor of hyperinsulinemia, suggesting significant metabolic consequences of intra-muscular lipid accumulation in this population. Our data suggest an overall schema whereby visceral fat hypertrophy may contribute to intra-muscular fat accumulation and hyperinsulinemia. Increased lipolysis in association with visceral adiposity may result in increased FFA levels that accumulate in the muscle, particularly if there is relatively less subcutaneous or extremity fat to serve as a depot for fat substrate. In turn, excess intramyocellular lipid may reduce glucose uptake into the muscle through effects on PI-3 kinase and thereby contribute to insulin resistance. Because of the cross-sectional nature of this study, we cannot determine causality, and it is also plausible that insulin resistance as a primary event impairs insulin mediated inhibition of lipolysis, resulting in excess free fatty acids and lipid accumulation in the muscle. Furthermore, Luzi et al. (22) demonstrated decreased lipid oxidation rates in association with increased intramyocellular lipid accumulation among HIV-infected patients receiving antiretroviral therapy, but regional and whole body lipolytic rates were not quantified. Although skeletal muscle fat content can be estimated on the basis of X-ray attenuation value by CT (6; 7; 14; 28), this methodology is incapable of directly measuring muscle lipid content and distinction of intramyocellular and extramyocellular fat is not possible. Proton magnetic resonance (MR) spectroscopy has been recently validated as an effective and specific method to directly quantify skeletal muscle lipids (4; 35), with reliable results correlating intramyocellular lipids with biopsy samples (19) and insulin sensitivity (34). This technique has been successfully employed by Gan et al. (13), who found increased intra-muscular lipid in association with insulin resistance in HIV-lipodystrophy patients. Nevertheless, single-slice CT scanning as performed in this study, appears to be effective for assessment of body composition and overall psoas muscle adiposity overcoming anatomical limitations of MR spectroscopy that is limited to two muscles of the lower leg. The capability of quantifying attenuation in a variety of muscles as well as fat distribution around muscle represent a
11 JAP significant advantage of CT methodology. The widespread availability of CT, relative low-cost and prompt acquisition of data also makes it well suited for large-scale clinical investigation. In summary, this study demonstrates decreased psoas muscle attenuation in HIVinfected patients with evidence of the lipodystrophy syndrome. Diminished psoas attenuation is associated with abnormal body composition, lipid and glucose metabolism in this population. Our data support the hypothesis that overaccumulation of intra-muscular lipids contributes to decreased insulin sensitivity and hyperinsulinemia in this population. Further studies investigating the pathogenesis of intra-muscular lipid accumulation and effects on glucose homeostasis are necessary to determine optimal treatment strategies for dyslipidemia and insulin resistance in HIV-infected patients.
12 JAP ACKNOWLEDGEMENTS We thank the nursing and bionutrition staff of the General Clinical Research Center at the Massachusetts General Hospital for their dedicated patient care.
13 JAP REFERENCES 1. Behrens GM, Boerner AR, Weber K, van den Hoff J, Ockenga J, Brabant G and Schmidt RE. Impaired glucose phosphorylation and transport in skeletal muscle cause insulin resistance in HIV-1-infected patients with lipodystrophy. J Clin Invest 110: , Bernasconi E, Boubaker K, Junghans C, Flepp M, Furrer HJ, Haensel A, Hirschel B, Boggian K, Chave JP, Opravil M, Weber R, Rickenbach M and Telenti A. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 31: 50-5, Boden G, Lebed B, Schatz M, Homko C and Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes 50: , Boesch C, Slotboom J, Hoppeler H and Kreis R. In vivo determination of intramyocellular lipids in human muscle by means of localized 1H-MR-spectroscopy. Magn Reson Med 37: , Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK and Silbert JE. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 36: 172-7, Buckley DC, Kudsk KA, Rose BS, Fatzinger P, Koetting CA and Schlatter M. Anthropometric and computerized tomographic measurements of lower extremity lean body mass. J Am Diet Assoc 87: 196-9, Bulcke JA, Crolla D, Termote JL, Baert A, Palmers Y and Van den Bergh R. Computed tomography of muscle. Muscle Nerve 4: 67-72, 1981.
14 JAP Carr A, Miller J, Law M and Cooper DA. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14: F25-32, Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ and Cooper DA. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12: F51-8, Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ and Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor- associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study. Lancet 353: , Chalkley SM, Hettiarachchi M, Chisholm DJ and Kraegen EW. Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47: , Chene G, Angelini E, Cotte L, Lang JM, Morlat P, Rancinan C, May T, Journot V, Raffi F, Jarrousse B, Grappin M, Lepeu G and Molina JM. Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients. Clin Infect Dis 34: , Gan SK, Samaras K, Thompson CH, Kraegen EW, Carr A, Cooper DA and Chisholm DJ. Altered Myocellular and Abdominal Fat Partitioning Predict Disturbance in Insulin Action in HIV Protease Inhibitor-Related Lipodystrophy. Diabetes 51: , Goodpaster BH, Kelley DE, Thaete FL, He J and Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol 89: , 2000.
15 JAP Goodpaster BH, Thaete FL and Kelley DE. Thigh adipose tissue distribution is associated with insulin resistance in obesity and in type 2 diabetes mellitus. Am J Clin Nutr 71: , Goodpaster BH, Thaete FL, Simoneau JA and Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 46: , Hadigan C, Borgonha S, Rabe J, Young V and Grinspoon S. Increased rates of lipolysis among human immunodeficiency virus- infected men receiving highly active antiretroviral therapy. Metabolism 51: , Hadigan C, Rabe J, Meininger G, Aliabadi N, Breu J and Grinspoon S. Inhibition of lipolysis improves insulin sensitivity in protease inhibitor-treated HIV-infected men with fat redistribution. Am J Clin Nutr 77: 490-4, Howald H, Boesch C, Kreis R, Matter S, Billeter R, Essen-Gustavsson B and Hoppeler H. Content of intramyocellular lipids derived by electron microscopy, biochemical assays, and (1)H-MR spectroscopy. J Appl Physiol 92: , Kratz A and Lewandrowski KB. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N Engl J Med 339: , Lo JC, Mulligan K, Tai VW, Algren H and Schambelan M. "Buffalo hump" in men with HIV-1 infection. Lancet 351: , Luzi L, Perseghin G, Tambussi G, Meneghini E, Scifo P, Pagliato E, Del Maschio A, Testolin G and Lazzarin A. Intramyocellular lipid accumulation and reduced whole body
16 JAP lipid oxidation in HIV lipodystrophy. Am J Physiol Endocrinol Metab 284: E274-80, Mazess RB, Barden HS, Bisek JP and Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone- mineral and soft-tissue composition. Am J Clin Nutr 51: , Meininger G, Hadigan C, Laposata M, Brown J, Rabe J, Louca J, Aliabadi N and Grinspoon S. Elevated concentrations of free fatty acids are associated with increased insulin response to standard glucose challenge in human immunodeficiency virus-infected subjects with fat redistribution. Metabolism 51: 260-6, Meininger G, Hadigan C, Rietschel P and Grinspoon S. Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men. Am J Clin Nutr 76: , Metropolitan Life Insurance Company. Height and weight tables. Stat Bull Metrop Insur Co. 64: 2-9, Miller KK, Daly PA, Sentochnik D, Doweiko J, Samore M, Basgoz NO and Grinspoon SK. Pseudo-Cushing's syndrome in human immunodeficiency virus-infected patients. Clin Infect Dis 27: 68-72, Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D and Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85: , Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB and Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-8, 1997.
17 JAP Petersen KF and Shulman GI. Pathogenesis of skeletal muscle insulin resistance in type 2 diabetes mellitus. Am J Cardiol 90: 11G-18G, Rietschel P, Hadigan C, Corcoran C, Stanley T, Neubauer G, Gertner J and Grinspoon S. Assessment of growth hormone dynamics in human immunodeficiency virus- related lipodystrophy. J Clin Endocrinol Metab 86: , Saint-Marc T, Partisani M, Poizot-Martin I, Rouviere O, Bruno F, Avellaneda R, Lang JM, Gastaut JA and Touraine JL. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 14: 37-49, Sekhar RV, Jahoor F, White AC, Pownall HJ, Visnegarwala F, Rodriguez-Barradas MC, Sharma M, Reeds PJ and Balasubramanyam A. Metabolic basis of HIVlipodystrophy syndrome. Am J Physiol Endocrinol Metab 283: E332-7, Sinha R, Dufour S, Petersen KF, LeBon V, Enoksson S, Ma YZ, Savoye M, Rothman DL, Shulman GI and Caprio S. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes 51: , Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD and Stein DT. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276: E977-89, Vigouroux C, Gharakhanian S, Salhi Y, Nguyen TH, Chevenne D, Capeau J and Rozenbaum W. Diabetes, insulin resistance and dyslipidaemia in lipodystrophic HIVinfected patients on highly active antiretroviral therapy (HAART). Diabetes Metab 25: 225-
18 32, JAP
19 JAP Figure 1. Axial computerized tomography of the abdomen obtained at level of L4 showing subcutaneous fat (SC) and intra-abdominal (visceral) fat (IA) interspersed between bowel loops. Placement of regions of interest used to measure psoas (P) attenuation values is shown.
20 JAP Figure 2. Median and interquartile range for psoas muscle attenuation in HIV LIPO (n = 22), HIV NONLIPO (n = 20), and 21 HIV-negative age- and BMI-matched control subjects. *, P = 0.05 vs. NONLIPO;, P = vs. controls;, P = 0.04 vs. controls
21 JAP Table 1. Group comparison by lipodystrophy and HIV status HIV-infected lipodystrophic (n = 22) HIV-infected nonlipodystrophic (n = 20) Normal controls (n = 21) Age, anthropometrics and disease status Age (yr) 47 (38-50) 41 (37-44) 43 (37-49) Waist- to-hip ratio 0.99 ( ) a,c 0.91 ( ) 0.92 ( ) CD4+ T-cells (#/mm 3 ) 371 ( ) 313 ( ) NA HIV Viral load (copies/ml) 89 ( ) ( ) NA Duration of HIV (yr) 9 (6-10) c 6 (4-8) NA NRTI use (%) 100 c 60 NA PI use (%) 90 c 45 NA Body composition BMI (kg/m 2 ) 24.6 ( ) 24.4 ( ) 24.8 ( ) Whole-body fat by DEXA 14.1 ( ) 14.6 ( ) 16.7 ( ) (kg) Trunk fat : Total Fat by 0.61 ( ) a,c 0.46 ( ) 0.49 ( ) DEXA (kg) Extremity fat : Total Fat by 0.31 ( ) a,c 0.46 ( ) 0.44 ( ) DEXA (kg) Visceral fat area by CT 158 ( ) a,c 76 (51-112) 88 (62-116) (cm 2 ) Subcutaneous fat area by 118 (69-184) 118 (99-181) 159 ( ) CT (cm 2 ) VAT: abdominal crosssectional 0.25 ( ) a,c 0.15 ( ) 0.14 ( ) area by CT Psoas muscle density by 55.0 ( ) a,d 57.0 ( ) e 59.5 ( ) CT (HU) Metabolic status FFA (mmol/l) 0.62 ( ) 0.56 ( ) 0.58 ( ) HDL (mg/dl) 36 (30-41) a,d 44 (36-50) 47 (40-58) LDL (mg/dl) 114 (82-143) 92 (76-123) 96 (77-122) Triglycerides (mg/dl) 189 ( ) a,c 117 (74-182) e 75 (50-101) Cholesterol (mg/dl) 193 ( ) b,d 164 ( ) 169 ( ) Fasting glucose (mg/dl) 93 (85-98) 94 (89-97) 90 (85-95) ( OGTT glucose response, ( ) a ( AUC [mg/dl (120 min)] 18518) e 16478) Fasting insulin (µiu/ml) 11.5 ( ) a 8.7 ( ) 7.8 ( ) OGTT insulin response, AUC [µiu/ml (120 min)] 8389 ( ) b,d 4781 ( ) 4748 ( ) NRTI, nucleoside reverse transcriptase inhibitor; PI, protease inhibitor; FFA, Plasma free fatty acids; OGTT, Oral glucose tolerance test, NA, not applicable. For HIV-infected lipodystrophic patients vs. controls, a indicates P < 0.01 and b indicates P < For HIV-infected lipodystrophic vs. HIV infected nonlipodystrophic patients, c indicates P < 0.01 and d indicates P < For HIV-infected nonlipodystrophic patients vs. controls, e indicates P < Results are median (interquartile range).
22 JAP Table 2. Univariate correlations of body composition, WHR, and metabolic status with psoas muscle density in HIV-infected subjects Psoas muscle density (HU) r value P value Body composition and anthropometrics BMI WHR Visceral fat by CT Subcutaneous fat by CT Whole-body fat by DEXA Trunk fat by DEXA Metabolic status FFA LDL cholesterol Triglycerides Cholesterol Glucose response to OGTT (AUC) Fasting insulin Insulin response to OGTT (AUC) FFA, plasma free fatty acids; OGTT, oral glucose tolerance test.
23 JAP Table 3. Forward stepwise regression analysis of HIV-infected patients Dependent variable Parameter estimate Stepwise P Psoas muscle attenuation (r 2 = 0.39 for whole model, P = 0.1 to enter) Visceral fat by CT (cm 2 ) Plasma FFA (mmol/l) BMI (kg/m 2 ) Subcutaneous fat by CT (cm 2 ) NA 0.89 PI Use NA 0.49 NRTI Use NA 0.82 Insulin AUC (r 2 = 0.47 for whole model, P = 0.1 to enter) Visceral fat by CT (cm 2 ) Psoas muscle attenuation (HU) Plasma FFA (mmol/l) NA 0.31 Subcutaneous fat by CT (cm 2 ) NA 0.38 BMI (kg/m 2 ) NA 0.21 PI Use NA 0.53 NRTI Use NA 0.67 PI, Protease inhibitor; NRTI, Nucleoside reverse transcriptase inhibitor; NA, not applicable.
Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men 1 3
Body-composition measurements as predictors of glucose and insulin abnormalities in HIV-positive men 1 3 Gary Meininger, Colleen Hadigan, Petra Rietschel, and Steven Grinspoon ABSTRACT Background: Fat
More informationColleen Hadigan, 1 Shafali Jeste, 1 Ellen J. Anderson, 2 Rita Tsay, 3 Helen Cyr, 3 and Steven Grinspoon 1. Kenneth H. Mayer, Section Editor
HIV/AIDS Kenneth H. Mayer, Section Editor MAJOR ARTICLE Modifiable Dietary Habits and Their Relation to Metabolic Abnormalities in Men and Women with Human Immunodeficiency Virus Infection and Fat Redistribution
More informationX/01/$03.00/0 Vol. 86, No. 2 The Journal of Clinical Endocrinology & Metabolism Copyright 2001 by The Endocrine Society
0021-972X/01/$03.00/0 Vol. 86, No. 2 The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright 2001 by The Endocrine Society Assessment of Growth Hormone Dynamics in Human Immunodeficiency
More informationDidactic Series. Lipohypertrophy in HIV
Didactic Series Lipohypertrophy in HIV Daniel Lee, MD Clinical Professor of Medicine UCSD Medical Center Owen Clinic August 14th, 2014 ACCREDITATION STATEMENT: University of California, San Diego School
More informationALIPODYSTROPHY SYNDROME
PRELIMINARY COMMUNICATION in the Treatment of HIV Lipodystrophy Syndrome A Randomized Controlled Trial Colleen Hadigan, MD Colleen Corcoran, NP Nesli Basgoz, MD Benjamin Davis, MD Paul Sax, MD Steven Grinspoon,
More informationMechanisms and Strategies for Insulin Resistance in Acquired Immune Deficiency Syndrome
SUPPLEMENT ARTICLE Mechanisms and Strategies for Insulin Resistance in Acquired Immune Deficiency Syndrome Steven Grinspoon Harvard Medical School, Massachusetts General Hospital, Program in Nutritional
More informationA Pilot Study of Exercise Training to Reduce Trunk Fat in Adults With HIV Associated Fat Redistribution
A Pilot Study of Exercise Training to Reduce Trunk Fat in Adults With HIV Associated Fat Redistribution Ronenn Roubenoff, Lauren Weiss, Ann McDermott, Tanya Heflin, Gregory J. Cloutier, Michael Wood and
More informationMetabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy
HIV/AIDS MAJOR ARTICLE Metabolic Abnormalities and Cardiovascular Disease Risk Factors in Adults with Human Immunodeficiency Virus Infection and Lipodystrophy Colleen Hadigan, 1,4 James B. Meigs, 3 Colleen
More informationRelationship Between Neck Circumference and Cardiometabolic Parameters in HIV- Infected and non HIV-Infected Adults
Relationship Between Neck Circumference and Cardiometabolic s in HIV- Infected and non HIV-Infected Adults The Harvard community has made this article openly available. Please share how this access benefits
More informationWhat is Malnutrition?
HIV & Obesity Gail Shor-Posner, PhD Director, Division of Disease Prevention Department of Epidemiology & Public Health University of Miami Miller School of Medicine What is Malnutrition? Under-nutrition
More informationVisceral adipose tissue and carotid intimamedia thickness in HIV-infected patients undergoing cart: a prospective cohort study
Beires et al. BMC Infectious Diseases (2018) 18:32 DOI 10.1186/s12879-017-2884-9 RESEARCH ARTICLE Visceral adipose tissue and carotid intimamedia thickness in HIV-infected patients undergoing cart: a prospective
More informationTesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies
Tesamorelin Clinical Data Overview Jean-Claude Mamputu, PhD Senior Medical Advisor, Theratechnologies Copyright 2016. All Rights Reserved. Property of Theratechnologies Inc. Mechanism of Action of Tesamorelin
More informationTOXICITY, TOLERABILITY, AND ADHERENCE TO THERAPY
SAFETY AND TOLERABILITY OF CURRENTLY AVAILABLE ANTIRETROVIRAL AGENTS * Esteban Martinez, MD, PhD ABSTRACT Safety and tolerability are important factors to consider when instituting or modifying therapy
More informationGrowth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials
DOI: 10.1111/j.1468-1293.2010.00906.x r 2011 British HIV Association HIV Medicine (2011), 12, 453 462 REVIEW Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled
More informationThe Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1 Patient: Birth Date: 48.2 years Height / Weight: 150.0 cm 72.0 kg Sex / Ethnic: Female
More informationThe Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
Birth Date: 40.2 years Height / Weight: 158.0 cm 52.0 kg Sex / Ethnic: Female Patient ID: Total Body Tissue Quantitation Composition Reference: Total Tissue 50% 40% 30% 20% 20 30 40 50 60 70 80 90 100
More informationThe Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1 Patient: Birth Date: 43.4 years Height / Weight: 170.0 cm 66.0 kg Sex / Ethnic: Female
More informationVisceral and Subcutaneous Adiposity Measurements in Adults: Influence of Measurement Site
Human Physiology Visceral and Subcutaneous Adiposity Measurements in Adults: Influence of Measurement Site Kenneth J. Ellis,* Birgit Grund, Fehmida Visnegarwala,* Lisa Thackeray, Collin G. Miller, Charles
More informationThe Bone Wellness Centre - Specialists in Dexa Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
Birth Date: 24.7 years Height / Weight: 8.0 cm 79.0 kg Sex / Ethnic: Male Patient ID: Total Body Tissue Quantitation Composition Reference: Total Tissue 40% 30% 20% 0% 20 30 40 50 60 70 80 90 00 Centile
More informationCardiovascular Disease Risk Factors Among HIV Patients
ISSN: 23776196 The American Journal of SCIENCE AND MEDICAL RESEARCH, 1(1), 92100 Research Article Cardiovascular Disease Risk Factors Among HIV Patients Open Access P. Sanjeev Reddy Government Junior College,
More informationThe Bone Wellness Centre - Specialists in Dexa Total Body 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
Patient: Obese, Sample Birth Date: 0/Jan/966 44.4 years Height / Weight: 72.0 cm 95.0 kg Sex / Ethnic: Male Patient ID: Referring Physician: DR. SMITH Measured: 07/Jun/200 7:0:52 PM (.40) Analyzed: 02/Apr/203
More informationJuvenile obesity is the most prevalent nutritional
Assessment of Skeletal Muscle Triglyceride Content by 1 H Nuclear Magnetic Resonance Spectroscopy in Lean and Obese Adolescents Relationships to Insulin Sensitivity, Total Body Fat, and Central Adiposity
More informationElevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with
Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with Insulin Resistance Mehrnoosh Shanaki, Ph.D. Assistant Professor of Clinical Biochemistry Shahid Beheshti
More informationContribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level
Antiviral Therapy 8:617-626 Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level David Nolan, Emma Hammond, Ian James, Elizabeth
More information3/25/2010. Age-adjusted incidence rates for coronary heart disease according to body mass index and waist circumference tertiles
Outline Relationships among Regional Adiposity, Physical Activity, and CVD Risk Factors: Preliminary Results from Two Epidemiologic Studies Molly Conroy, MD, MPH Obesity Journal Club February 18, 2010
More informationFat redistribution on ARVs: dogma versus data
Fat redistribution on ARVs: dogma versus data Gary Maartens Division of Clinical Pharmacology UNIVERSITY OF CAPE TOWN IYUNIVESITHI YASEKAPA UNIVERSITEIT VAN KAAPSTAD Half of what we are going to teach
More informationEffect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation A Randomized Clinical Trial
Research Original Investigation Effect of on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation A Randomized Clinical Trial Takara L. Stanley, MD; Meghan N. Feldpausch,
More informationEffect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome
ORIGINAL RESEARCH Effect of extended-release niacin on hormone-sensitive lipase and lipoprotein lipase in patients with HIV-associated lipodystrophy syndrome Dominic C Chow Anne Tasaki Jill Ono Bruce Shiramizu
More informationIschemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection
HIV/AIDS MAJOR ARTICLE Ischemic Cardiovascular Disease in Persons with Human Immunodeficiency Virus Infection Max H. David, 1,3 Richard Hornung, 2 and Carl J. Fichtenbaum 1 1 Department of Medicine, Division
More informationLipoatrophy and Fat Accumulation in HIV-Infected Adults
Switch to a PI-Containing/NRTI-Sparing regimen (LPVr/EFV) increases appendicular fat content and serum lipid levels without affecting glucose metabolism or bone mineral density. The results of a prospective
More informationSkeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content
J Appl Physiol 89: 104 110, 2000. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content BRET H. GOODPASTER, 1 DAVID E. KELLEY, 1 F. LELAND THAETE,
More informationChanges and clinical significance of serum vaspin levels in patients with type 2 diabetes
Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu
More informationMonitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy
HORMONES 2011, 10(2):149-155 Research paper Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy Vana Spoulou, 1 Christina Kanaka-Gantenbein, 1
More informationThe Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1
The Bone Wellness Centre - Specialists in DEXA Scanning 855 Broadview Avenue Suite # 305 Toronto, Ontario M4K 3Z1 Patient: Birth Date: 29.5 years Height / Weight: 156.0 cm 57.0 kg Sex / Ethnic: Female
More informationPrevalence of Comorbidities among HIV-positive patients in Taiwan
Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity
More informationUMHS-PUHSC JOINT INSTITUTE
Role of Visceral Adiposity in the Pathogenesis of Non-Alcoholic Fatty Liver Disease in Lean versus Obese Patients: A Comparative Study between Patients at UMHS versus PUHSC Lai WEI and Anna LOK W Zhang,
More informationRole of fatty acids in the development of insulin resistance and type 2 diabetes mellitus
Emerging Science Role of fatty acids in the development of insulin resistance and type 2 diabetes mellitus George Wolf Insulin resistance is defined as the reduced responsiveness to normal circulating
More informationSubcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
Administrator Access Store Join Endocrine Society Sign In Advanced Search 0 ITEMS Journals Books Meeting Abstracts Endocrine News Advertise Permissions ISSN (print journal): 0163-769X ISSN (online): 1945-7189
More informationARIC Manuscript Proposal # 1618
ARIC Manuscript Proposal # 1618 PC Reviewed: 3/9/10 Status: A Priority: 2 SC Reviewed: Status: Priority: 1.a. Full Title: Does physical activity modify the association between plasma fatty acids and incident
More informationEPIDEMIOLOGICAL studies often report an association
0163-769X/00/$03.00/0 Endocrine Reviews 21(6): 697 738 Copyright 2000 by The Endocrine Society Printed in U.S.A. Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome BERNARDO
More informationCarol Davila University of Medicine and Pharmacy, Bucharest, Romania
Mædica - a Journal of Clinical Medicine MAEDICA a Journal of Clinical Medicine 2016; 11(5): 32-37 ORIGINAL PAPER Changes in Fasting Plasma Glucose, HbA1c and Triglycerides Are Related to Changes in Body
More informationHIV Infection as a Chronic Disease. Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School
HIV Infection as a Chronic Disease Howard Libman, MD Beth Israel Deaconess Medical Center Harvard Medical School Role of Primary Care Approximately 50,000 patients are diagnosed with HIV infection annually
More informationImpact of Exercise on Patients with Diabetes Mellitus
Impact of Exercise on Patients with Diabetes Mellitus Bret Goodpaster, Ph.D. Exercise Physiologist Assistant Professor of Medicine University of Pittsburgh Division of Endocrinology and Metabolism Learning
More informationHuman Nutrition and Metabolism
Human Nutrition and Metabolism A Comparison of Abdominal Subcutaneous Adipose Tissue Pattern in Obese and Lean HIV-Infected Women 1 Qing He, Ellen S. Engelson, and Donald P. Kotler 2 Division of Gastroenterology,
More informationReview Article The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy in HIV-Infected Patients
Hindawi Publishing Corporation PPAR Research Volume 2009, Article ID 373524, 15 pages doi:10.1155/2009/373524 Review Article The Effects of Thiazolidinediones on Metabolic Complications and Lipodystrophy
More informationAssociation of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction
CLINICAL SCIENCE Association of C-Reactive Protein and HIV Infection With Acute Myocardial Infarction Virginia A. Triant, MD, MPH,* James B. Meigs, MD, MPH, and Steven K. Grinspoon, MD Objective: To investigate
More informationBody composition analysis by dual energy X-ray absorptiometry in female diabetics differ between manufacturers
European Journal of Clinical Nutrition (1997) 51, 449±454 ß 1997 Stockton Press. All rights reserved 0954±3007/97 $12.00 Body composition analysis by dual energy X-ray absorptiometry in female diabetics
More informationABSTRACT THE ENDOCRINE SOCIETY 2001 ACCEPTED SPONSOR J.D.Wilson, M.D.
STREET C, SCALLY MC. Pharmaceutical Intervention of Anabolic Steroid Induced Hypogonadism - Our Success at Restoration of the HPG Axis. Medicine and Science in Sports and Exercise 2000;32(5)Suppl. High-dose
More informationHormonal and Metabolic Disorders of Human Immunodeficiency Virus Infection and Substance Abuse
American Journal of Infectious Diseases 2 (3): 125-129, 2006 ISSN 1553-6203 2006 Science Publications Hormonal and Metabolic Disorders of Human Immunodeficiency Virus Infection and Substance Abuse Jag
More informationWIHS Metabolic Working Group Summary
Metabolics Prepared by: Phyllis Tien on behalf of the Metabolic Working Group WIHS Metabolic Working Group Summary Aims of the Metabolic Working Group: To examine the role of chronic inflammation, coinfections,
More informationOsteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy Andrew Carr a, John Miller b, John A. Eisman c and David A. Cooper a,b Background:
More informationHeart Online First, published on March 29, 2005 as /hrt SCIENTIFIC LETTER
Heart Online First, published on March 29, 2005 as 10.1136/hrt.2004.056523 Manuscript ID: HEARTJNL/2004/056523 March 18, 2005 SCIENTIFIC LETTER Effects of HMG-CoA Reductase Inhibition on Endothelial Function
More informationThe Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients
American Journal of Infectious Diseases 4 (2): 147-151, 2008 ISSN 1553-6203 2008 Science Publications The Lipid-Lowering Efficacy of Switching Within Non-Nucleoside Reverse Transcriptase Inhibitors in
More informationThe Impact Of Adiposity And Insulin Resistance On Endothelial Function In Middle-Aged Subjects
ISPUB.COM The Internet Journal of Cardiovascular Research Volume 1 Number 1 The Impact Of Adiposity And Insulin Resistance On Endothelial Function In Middle-Aged Subjects L Zhu, K Liu Citation L Zhu, K
More informationObesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians
Obesity and the Metabolic Syndrome in Developing Countries: Focus on South Asians Anoop Misra Developing countries, particularly South Asian countries, are witnessing a rapid increase in type 2 diabetes
More informationThe Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health
More informationSUPPLEMENTARY DATA. Imaging Studies.
Imaging Studies. Dexa Total body composition (fat mass and fat-free mass) was measured by dual-energy x-ray absorptiometry using a scanner (Hologic, Inc., Boston, MA). Dual-energy x-ray absorptiometry
More informationHow to assess it at the bedside and in a research protocol
ESPEN Congress Nice 2010 Body composition How to assess it at the bedside and in a research protocol Andrea Rossi Mauro Zamboni Body composition: How to assess it at bedside and in a research protocol
More informationLeptin levels and menstrual function in HIV-infected women in rural India
Leptin levels and menstrual function in HIV-infected women in rural India Annie Phoebe. K¹, Mini Jacob.S¹, Hemalatha.R², Sivakumar M.R¹ ¹Department of Experimental Medicine, The Tamil Nadu Dr. MGR Medical
More informationΛΟΙΜΩΞΗ HIV. Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική
ΛΟΙΜΩΞΗ HIV Ιγνάτιος Οικονομίδης,MD,FESC Β Πανεπιστημιακή Καρδιολογική Κλινική, Νοσοκομείο «Αττικόν» Infection Acute Myocardial Infarction p er 100,000 HIV/AIDS discharg es 800 700 600 500 400 300 200
More informationPerspectives Management of Dyslipidemia and Other Cardiovascular Risk Factors in HIV-Infected Patients: Case-based Review
International AIDS Society USA Topics in HIV Medicine Perspectives Management of Dyslipidemia and Other Cardiovascular Risk Factors in HIV-Infected Patients: Case-based Review Many HIV-infected patients
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationMetabolic Syndrome in Asians
Metabolic Syndrome in Asians Alka Kanaya, MD Asst. Professor of Medicine, UCSF Asian CV Symposium, November 17, 2007 The Metabolic Syndrome Also known as: Syndrome X Insulin Resistance Syndrome The Deadly
More informationAn evaluation of body mass index, waist-hip ratio and waist circumference as a predictor of hypertension across urban population of Bangladesh.
An evaluation of body mass index, waist-hip ratio and waist circumference as a predictor of hypertension across urban population of Bangladesh. Md. Golam Hasnain 1 Monjura Akter 2 1. Research Investigator,
More informationGrowth of Visceral Fat, Subcutaneous Abdominal Fat, and Total Body Fat in Children
Growth of Visceral Fat, Subcutaneous Abdominal Fat, and Total Body Fat in Children Terry T.-K. Huang,* Maria S. Johnson,* Reinaldo Figueroa-Colon, James H. Dwyer,* and Michael I. Goran* Abstract HUANG,
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationFAT. It s Not All That! A Closer Look at the Two Main Types of Fat in Our Bodies: Visceral and Subcutaneous Fat
Mary-Kate Perrone Capstone Seminar July 14, 2007 Draft #2 Fat Stats FAT. It s Not All That! A Closer Look at the Two Main Types of Fat in Our Bodies: Visceral and Subcutaneous Fat According to the 2003-2004
More informationDyslipidemia and Its Relation with Body Mass Index Versus Waist Hip Ratio
Dyslipidemia and Its Relation with Body Mass Index Versus Waist Hip Ratio Pages with reference to book, From 308 To 310 Abdul Jabbar, Asad Irfanullah, Jaweed Akhter, Y.K. Mirza ( Department of Medicine,
More informationDUAL ENERGY X-RAY ABSORPTIOMETRY (DXA) GOLD STANDARD FOR BONE HEALTH AND BODY COMPOSITION ASSESSMENT
DUAL ENERGY X-RAY ABSORPTIOMETRY (DXA) GOLD STANDARD FOR BONE HEALTH AND BODY COMPOSITION ASSESSMENT Prof d-r Slavica Šubeska Stratrova Clinic of Endocrinology, Skopje, Macedonia Definition and classification
More informationAssociation between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese
Diabetes Care Publish Ahead of Print, published online June 12, 2008 Raised Blood Pressure and Dysglycemia Association between Raised Blood Pressure and Dysglycemia in Hong Kong Chinese Bernard My Cheung,
More informationFat Mass. Baseline. (lbs) (lbs) Composition Trend: Total. Aug 17. Apr 17. May 17. Jun 17. Jul 17. Measured Date
Name Sample Report Birth Date: 00/00/000 Height: 74.0 in. Gender Male Age: 54.7 Input Weight: 165.0 lbs. Body Composition Analysis (BCA) DXA or DEXA is a three component model, which means it quantifies
More informationUnderstanding Body Composition
Understanding Body Composition Chapter 7 Body Composition n Body composition is the ratio between fat and fat-free mass n Fat-free mass includes all tissues exclusive of fat (muscle, bone, organs, fluids)
More informationOXIDATION OF FFA is a fundamental biochemical
0013-7227/02/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 87(5):2139 2143 Printed in U.S.A. Copyright 2002 by The Endocrine Society Metabolic Characterization of a Woman Homozygous for the
More informationAuthor Manuscript Faculty of Biology and Medicine Publication
Serveur Académique Lausannois SERVAL serval.unil.ch Author Manuscript Faculty of Biology and Medicine Publication This paper has been peer-reviewed but does not include the final publisher proof-corrections
More informationPrevalence of Lipodystrophy and Dyslipidemia among Patients with HIV Infection on Generic ART in Rural South India
Prevalence of Lipodystrophy and Dyslipidemia among Patients with HIV Infection on Generic ART in Rural South India Journal of the International Association of Physicians in AIDS Care 11(5) 329-334 ª The
More informationHigher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir
6131_06_p333-337 4/5/06 10:28 AM Page 333 AIDS RESEARCH AND HUMAN RETROVIRUSES Volume 22, Number 4, 2006, pp. 333 337 Mary Ann Liebert, Inc. Higher Risk of Hyperglycemia in HIV-Infected Patients Treated
More informationCellular mechanisms of insulin resistance
Cellular mechanisms of insulin resistance Gerald I. Shulman J Clin Invest. 2000;106(2):171-176. https://doi.org/10.1172/jci10583. Perspective It is estimated that by the year 2020 there will be approximately
More informationNAFLD AND TYPE 2 DIABETES
NAFLD AND TYPE 2 DIABETES Sonia Caprio, MD STOPNASH Symposium on the Origin and Pathways of Nonalcoholic Steatohepatitis Washington 7, 215 Global Projection of Diabetes Hossain P et al. N Engl J Med 27;356:213
More informationORIGINAL INVESTIGATION
ORIGINAL INVESTIGATION Effects of a Supervised Home-Based Aerobic and Progressive Resistance Training Regimen in Women Infected With Human Immunodeficiency Virus A Randomized Trial Sara E. Dolan, MSN,
More informationCardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
The new england journal of medicine review article From the Program in Nutritional Metabolism and the Neuroendocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston (S.G.); and
More informationIMPROVEMENT in LIPOATROPHY ASSOCIATED with HIGHLY ACTIVE ANTIRETROVIRAL THERAPY in HIV-INFECTED CHILDREN SWITCHED from STAVUDINE to TENOFOVIR
Poster R-105 IMPROVEMENT in LIPOATROPHY ASSOCIATED with HIGHLY ACTIVE ANTIRETROVIRAL THERAPY in HIV-INFECTED CHILDREN SWITCHED from STAVUDINE to TENOFOVIR ALESSANDRA VIGANO 1, PAOLO BRAMBILLA 1, LAURA
More informationThe Metabolic Syndrome Update The Metabolic Syndrome Update. Global Cardiometabolic Risk
The Metabolic Syndrome Update 2018 Marc Cornier, M.D. Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine
More informationChapter 17: Body Composition Status and Assessment
Chapter 17: Body Composition Status and Assessment American College of Sports Medicine. (2010). ACSM's resource manual for guidelines for exercise testing and prescription (6th ed.). New York: Lippincott,
More informationCLINICAL SCIENCE. 1 4 In such patients, excess central fat is usually visceral, 9,10 Although studies linking increased WC to mortality
CLINICAL SCIENCE Effects of Tesamorelin, a Growth Hormone Releasing Factor, in HIV-Infected Patients With Abdominal Fat Accumulation: A Randomized Placebo-Controlled Trial With a Safety Extension Julian
More informationBody Habitus Changes Related to Lipodystrophy
SUPPLEMENT ARTICLE Body Habitus Changes Related to Lipodystrophy Fred Sattler Keck School of Medicine, University of Southern California, Los Angeles, California Changes in body fat in persons infected
More informationUpper-body obesity, especially when associated. Similar VLDL-TG Storage in Visceral and Subcutaneous Fat in Obese and Lean Women
BRIEF REPORT Similar VLDL-TG Storage in Visceral and Subcutaneous Fat in Obese and Lean Women Esben Søndergaard, 1 Birgitte Nellemann, 1 Lars P. Sørensen, 1 Lars C. Gormsen, 2 Jens S. Christiansen, 1 Erik
More informationRelationship of Waist Circumference and Lipid Profile in Children
International Journal of Biomedical Science and Engineering 2015; 3(3): 44-48 Published online May 28, 2015 (http://www.sciencepublishinggroup.com/j/ijbse) doi: 10.11648/j.ijbse.20150303.12 ISSN: 2376-7227
More informationLipid Profile, Cardiovascular Risk Factors and Metabolic Syndrome in a Group of AIDS Patients
Lipid Profile, Cardiovascular Risk Factors and Metabolic Syndrome in a Group of AIDS Patients Érika Ferrari Rafael da Silva 1, Katia Cristina Bassichetto 2, David Salomão Lewi 1 Universidade Federal de
More informationCut-Off Values of Visceral Fat Area and Waist-to-Height Ratio: Diagnostic Criteria for Obesity-Related Disorders in Korean Children and Adolescents
Original Article http://dx.doi.org/10.3349/ymj.2012.53.1.99 pissn: 0513-5796, eissn: 1976-2437 Yonsei Med J 53(1):99-105, 2012 Cut-Off Values of Visceral Fat Area and Waist-to-Height Ratio: Diagnostic
More informationUpper-body obesity, especially when associated. Similar VLDL-TG Storage in Visceral and Subcutaneous Fat in Obese and Lean Women
BRIEF REPORT Similar VLDL-TG Storage in Visceral and Subcutaneous Fat in Obese and Lean Women Esben Søndergaard, 1 Birgitte Nellemann, 1 Lars P. Sørensen, 1 Lars C. Gormsen, 2 Jens S. Christiansen, 1 Erik
More informationModule 2: Metabolic Syndrome & Sarcopenia. Lori Kennedy Inc & Beyond
Module 2: Metabolic Syndrome & Sarcopenia 1 What You Will Learn Sarcopenia Metabolic Syndrome 2 Sarcopenia Term utilized to define the loss of muscle mass and strength that occurs with aging Progressive
More informationWEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH
MENOPAUSE WHEN DOES IT OCCUR? The cessation of the menstrual cycle for one year. WEIGHT GAIN DURING MENOPAUSE EMERGING RESEARCH Jan Schroeder, Ph.D. Chair of The Department of Kinesiology California State
More informationSection II: Emerging Uses of Bone Densitometry
Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health, vol. 17, no. 1, 78e83, 2014 Ó Copyright 2014 by The International Society for Clinical Densitometry 1094-6950/17:78e83/$36.00
More informationTHEORIES ON OBESITY AND TYPE 2 DIABETES MELLITUS: PREDICTORS OF SHORT-TERM WEIGHT LOSS AND DISEASE PREVENTION IN ELEMENTARY SCHOOL CHILDREN
THEORIES ON OBESITY AND TYPE 2 DIABETES MELLITUS: PREDICTORS OF SHORT-TERM WEIGHT LOSS AND DISEASE PREVENTION IN ELEMENTARY SCHOOL CHILDREN Item Type text; Electronic Thesis Authors LANG, JESSICA CHRISTINE
More informationA study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital
Original Research Article A study of waist hip ratio in identifying cardiovascular risk factors at Government Dharmapuri College Hospital M. Arivumani * Assistant Professor of General Medicine, Government
More informationThe role of efavirenz compared with protease inhibitors in the body fat changes associated with highly active antiretroviral therapy
Journal of Antimicrobial Chemotherapy (2008) 62, 234 245 doi:10.1093/jac/dkn191 Advance Access publication 14 May 2008 The role of efavirenz compared with protease inhibitors in the body fat changes associated
More informationBone Mineral Density and Fatty Degeneration of Thigh Muscles Measured by Computed Tomography in Hip Fracture Patients
J Bone Metab 2016;23:215-221 https://doi.org/10.11005/jbm.2016.23.4.215 pissn 2287-6375 eissn 2287-7029 Original Article Bone Mineral Density and Fatty Degeneration of Thigh Muscles Measured by Computed
More information3TC (lamivudine, Epivir)
3TC (lamivudine, Epivir) Summary 3TC is a type of antiretroviral drug called a nucleoside analogue (or nuke ). 3TC can cause nausea, headache, diarrhea, vomiting and weakness; however, it causes few side
More informationWeighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body Weight. Nicola M. McKeown, PhD Scientist II
Weighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body Weight Nicola M. McKeown, PhD Scientist II Weighing in on Whole Grains: A review of Evidence Linking Whole Grains to Body
More information9/26/2018. Andy Weiler, M.Ed. September 26 th, 2018
Andy Weiler, M.Ed. September 26 th, 2018 1 2 Stay tuned for the answer to our riddle Riddle #2 3 Riddle #2 Riddle #2 4 Riddle #2 The answer: 50%/50% chance to be right Fluids: blood volume, body water,
More information